Cyclacel increases authorized common shares from 250M to 600M; removes Series E conversion cap

Bio Green Med Solution, Inc.

Board and majority stockholder approved Certificate of Amendment filed April 25, 2025.
Authorized common stock increased from 250,000,000 to 600,000,000 shares; no change to issued shares.
Amended Series E Certificate of Designation removes the 4.99% ownership limitation on conversion and voting.
Removal of Series E cap allows unlimited conversion of preferred into common shares going forward.
Both amendments effective upon filing with Delaware Secretary of State on April 25, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.